Geode Capital Management
BCAB icon

Geode Capital Management’s BioAtla BCAB Stock Holding History

Geode Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.1K Sell
12,819
-965
-7% -$4.09K ﹤0.01% 4231
2026
Q1 		$111K Buy
13,784
+3,777
+38% +$44.2K ﹤0.01% 4107
2025
Q4 		$284K Buy
10,007
+103
+1% +$4.04K ﹤0.01% 3795
2025
Q3 		$341K Buy
9,904
+59
+0.6% +$1.36K ﹤0.01% 3745
2025
Q2 		$195K Buy
9,845
+260
+3% +$5.27K ﹤0.01% 3885
2025
Q1 		$166K Buy
9,585
+1,185
+14% +$25.3K ﹤0.01% 3897
2024
Q4 		$248K Buy
8,400
+296
+4% +$24.8K ﹤0.01% 3825
2024
Q3 		$713K Buy
8,104
+13
+0.2% +$1.09K ﹤0.01% 3471
2024
Q2 		$554K Sell
8,091
-10,368
-56% -$1.23M ﹤0.01% 3533
2024
Q1 		$3.18M Buy
18,459
+377
+2% +$46.8K ﹤0.01% 2925
2023
Q4 		$2.22M Buy
18,082
+1,040
+6% +$90.2K ﹤0.01% 3060
2023
Q3 		$1.45M Buy
17,042
+420
+3% +$53.5K ﹤0.01% 3185
2023
Q2 		$2.49M Buy
16,622
+9,113
+121% +$1.57M ﹤0.01% 3043
2023
Q1 		$1.01M Buy
7,509
+463
+7% +$83.4K ﹤0.01% 3343
2022
Q4 		$2.91M Buy
7,046
+1,623
+30% +$673K ﹤0.01% 2916
2022
Q3 		$2.09M Buy
5,423
+1,805
+50% +$591K ﹤0.01% 3073
2022
Q2 		$515K Sell
3,618
-604
-14% -$96.1K ﹤0.01% 3741
2022
Q1 		$1.05M Sell
4,222
-1,566
-27% -$655K ﹤0.01% 3595
2021
Q4 		$5.68M Buy
5,788
+2,015
+53% +$2.58M ﹤0.01% 2830
2021
Q3 		$5.55M Sell
3,773
-294
-7% -$573K ﹤0.01% 2844
2021
Q2 		$8.62M Buy
4,067
+168
+4% +$380K ﹤0.01% 2567
2021
Q1 		$9.91M Buy
3,899
+3,550
+1,017% +$9.1M ﹤0.01% 2377
2020
Q4 		$593K Buy
+349
New +$583K ﹤0.01% 3541

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's BCAB Position: Q2 2026 in Review

Geode Capital Management reduced its BioAtla (BCAB) stake by 7% in Q2 2026, selling an estimated $4.09K and leaving 12,819 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4231.

Geode Capital Management first reported a position in BCAB in Q4 2020 and has held it in 23 quarters since. The position peaked at $9.91M in Q1 2021. 19 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Geode Capital Management held 12,819 shares of BioAtla worth $53.1K as of Q2 2026.
  • Geode Capital Management sold 965 BioAtla shares in Q2 2026, an estimated $4.09K.
  • BioAtla made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4231 holding.
  • Geode Capital Management first reported a position in BioAtla in Q4 2020 and has held it in 23 quarters since.
  • Geode Capital Management's BioAtla position peaked at $9.91M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.